Enter your terms above and click the 'Search' button.

Showing articles 0 to 8 of 8 Filter Applied: HMGcoA reductase inhibitors (Click to remove) Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy NEJM 381:275-283, Case 22-2019, 2019 Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Study Neurol 70:2364-2370,2355, Goldstein,L.B.,et al, 2008 Statin-Associated Myasthenia Gravis Medicine 85:82-85, Purvin,V.,et al, 2006 Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk Neurol 66:1153-1158, Kumar,S.,et al, 2006 HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcomes Stroke 36:1298-1300, Moonis,M.,et al, 2005 Hypercholesterolemia, HMG-CoA Reductase Inhibitors, and Risk of Intracerebral Hemorrhage Stroke 35:1360-1364, Woo,D.,et al, 2004 Statin-Associated Myopathy JAMA 289:1681-1690, Thompson,P.D.,et al, 2003 Cholesterol-Lowering Agent Myopathy (CLAM) Neurol 41:1159-1160, London,S.F.,et al, 1991 Showing articles 0 to 8 of 8